Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-positive antibacterial activity.

MLA

Jarvest, Richard L., et al. “Optimisation of Aryl Substitution Leading to Potent Methionyl TRNA Synthetase Inhibitors with Excellent Gram-Positive Antibacterial Activity.” Bioorganic & Medicinal Chemistry Letters, vol. 13, no. 4, Feb. 2003, pp. 665–68. EBSCOhost, https://doi.org/10.1016/s0960-894x(02)01027-2.

APA

Jarvest, R. L., Berge, J. M., Brown, M. J., Brown, P., Elder, J. S., Forrest, A. K., Houge-Frydrych, C. S. V., O’Hanlon, P. J., McNair, D. J., Rittenhouse, S., & Sheppard, R. J. (2003). Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-positive antibacterial activity. Bioorganic & Medicinal Chemistry Letters, 13(4), 665–668. https://doi.org/10.1016/s0960-894x(02)01027-2

Chicago

Jarvest, Richard L, John M Berge, Murray J Brown, Pamela Brown, John S Elder, Andrew K Forrest, C S V Houge-Frydrych, et al. 2003. “Optimisation of Aryl Substitution Leading to Potent Methionyl TRNA Synthetase Inhibitors with Excellent Gram-Positive Antibacterial Activity.” Bioorganic & Medicinal Chemistry Letters 13 (4): 665–68. doi:10.1016/s0960-894x(02)01027-2.